Author: Shrestha, Ashish C.; Wijesundara, Danushka K.; Masavuli, Makutiro G.; Mekonnen, Zelalem A.; Gowans, Eric J.; Grubor-Bauk, Branka
Title: Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines Document date: 2019_4_30
ID: 141u6ax7_1
Snippet: Vaccines represent an effective strategy in the fight against infectious diseases and recent estimates suggest that vaccination prevents 2-3 million deaths every year [1] . The need for rapid and large scale vaccine production during epidemics against emerging pathogens is a major challenge in vaccine development [2] , including effective vaccines for antigenically diverse and versatile pathogens that successfully subvert host immunity such as hu.....
Document: Vaccines represent an effective strategy in the fight against infectious diseases and recent estimates suggest that vaccination prevents 2-3 million deaths every year [1] . The need for rapid and large scale vaccine production during epidemics against emerging pathogens is a major challenge in vaccine development [2] , including effective vaccines for antigenically diverse and versatile pathogens that successfully subvert host immunity such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), and malaria [3] [4] [5] .
Search related documents:
Co phrase search for related documents- effective strategy and host immunity: 1, 2, 3
- effective strategy and human immunodeficiency: 1, 2, 3, 4, 5, 6
- effective strategy and human immunodeficiency virus: 1, 2, 3, 4, 5, 6
- effective strategy and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- effective strategy and major challenge: 1, 2, 3, 4, 5
- effective strategy and scale vaccine: 1, 2
- effective strategy and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- effective vaccine and HIV human immunodeficiency virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- effective vaccine and host immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- effective vaccine and human immunodeficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- effective vaccine and human immunodeficiency virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- effective vaccine and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- effective vaccine and major challenge: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- effective vaccine and scale vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- effective vaccine and scale vaccine production: 1, 2, 3, 4
- effective vaccine and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- effective vaccine and vaccine development major challenge: 1
- emerge pathogen and major challenge: 1
- HIV human immunodeficiency virus and vaccine development major challenge: 1
Co phrase search for related documents, hyperlinks ordered by date